Clinical Trial

Fecal Microbiota Transplantation for Radiation Enteritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-05-03; most recent amendment 2025-03-27.
Trial Details
NCT Number NCT03516461
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Jiangxi Provincial Cancer Hospital
Conditions Radiation Enteritis
Enrollment 70 participants
Start Date 2018-01-07
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-30